Jonas Schoendube
Direktor/Vorstandsmitglied bei Cytena Bioprocess Solutions
Ursprung des Netzwerks ersten Grades von Jonas Schoendube
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
cytena GmbH
 cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany.
3
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jonas Schoendube
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Director of Finance/CFO | 1 |
| Public Communications Contact | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andre Gross | 1 |
| Peter Koltay | 1 |
| Benjamin Steimle | 1 |
- Börse
- Insiders
- Jonas Schoendube
- Unternehmensverbindungen
